Dr. Yvette Bazikian, MD

Dr. Bazikian practices at HCA Florida North Florida Hospital in Gainesville, Florida, part of HCA Healthcare.

Dr. Bazikian's NPI, 1073507000, was assigned on September 6, 2005. Dr. Bazikian graduated from Universidad Iberoamericana (UNIBE) in 2001. Dr. Bazikian holds Florida license ME92928.

Dr. Bazikian's primary practice is HCA Florida North Florida Hospital, at 6500 W Newberry Rd, Gainesville, FL 32605 in Alachua County. The practice phone is (352) 333-4100.

Dr. Bazikian's primary practice is HCA Florida North Florida Hospital in Gainesville, Florida, part of HCA Healthcare. The medical group on file is Hospital Internal Medicine, P.A.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bazikian practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Bazikian's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Bazikian is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bazikian's licenses on file in 2 states: Florida and Michigan.

Dmand AI lists acute stomach ulcer, anemia, bile duct problems, cardiac arrhythmia, cellulitis, chest pain, chest trauma and circulation problems among the conditions Dr. Bazikian treats.

CMS data shows 958 Medicare services from Dr. Bazikian across 6 procedure codes in 2024, for 291 Medicare patients. Medicare paid $66,254 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 291 Medicare patients who saw Dr. Bazikian in 2024. The largest group is 75 to 84, with 122 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bazikian's median patient age at 73, with 51% women.

In 2024, Dr. Bazikian wrote 82 Medicare Part D claims for 33 patients. 83% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $360 in total drug cost. In 2017, CMS named 74 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Bazikian for performance year 2024, reported as part of a group. Dr. Bazikian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Bazikian, published from 2019 to 2024. 2022 was the busiest year, with 5. Dr. Bazikian has published most often in Cureus. Dr. Bazikian's most frequent co-authors are Ariel Ruiz De Villa, Leora Tova Ruth Frimer, MD and Asad Haider, MD.

CMS Open Payments shows 2 general payments to Dr. Bazikian from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $36.

Dr. Bazikian graduated from Universidad Iberoamericana (UNIBE) in 2001.

Dr. Bazikian is in network with 3 carriers, including Excellus BlueCross BlueShield, CMS Medicare and GA State Medicaid. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.